Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 3, 2004, Pages 515-524

  Vojdani, Aristo ^a,b   Bazargan, Mohsen ^c   Vojdani, Elroy ^d   Samadi, John ^b   Nourian, Alen A ^a   Eghbalieh, Navid ^a   Cooper, Edwin L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Immunosciences Laboratories Inc   (United States)

^c CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE I; ANTIBODY; AUTOANTIBODY; DIPEPTIDYL PEPTIDASE I; DIPEPTIDYL PEPTIDASE IV; GLIADIN; GLIADIN ANTIBODY; HEAT SHOCK PROTEIN 60; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PEPTIDASE; PEPTIDE; PROTEIN; STREPTOKINASE; SUPERANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; AUTISM; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHILD; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BINDING;

ADOLESCENT; ADULT; AGED; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ANTIGENS, CD13; ANTIGENS, CD26; AUTISTIC DISORDER; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BINDING, COMPETITIVE; CHAPERONIN 60; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; DIPEPTIDYL PEPTIDASE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIADIN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PEPTIDE HYDROLASES; PROTEIN BINDING; STREPTOKINASE;

EID: 2442691701     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.3.515-524.2004     Document Type: Article

References (64)

1. Anderson, R. P., P. Degano, A. J. Godkin, D. P. Jewell, and A. V. Hill. 2000. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant antigen T-cell epitope. Nat. Med. 6:337-342.
2. Ansorge, S., F. Buhling, T. Hoffmann, T. Kahne, K. Neubert, and D. Reinhold. 1995. DPP IV/CD26 on human lymphocytes: functional roles in cell growth and cytokine regulation, p. 163-184. In B. Fleischer (ed.), Dipeptidyl peptidase IV (CD26) in metabolism and the immune response. Springer Verlag, Berlin, Germany.
3. Barret, A. J., N. D. Rawlings, and J. F. Woessner (ed.). 1998. Handbook of proteolytic enzymes, p. 379-382. Academic Press, New York, N.Y.
4. Broadley, S. A., J. Dean, S. J. Sawcer, D. Clayton, and D. A. S. Compston. 2000. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. Brain 123:1102-1111.
5. Bürk, K., S. Bösch, C. A. Müller, et al. 2001. Sporadic cerebellar ataxia associated with gluten sensitivity. Brain 124:1013-1019.
6. Chatchatee, P., K. M. Järviven, L. Bardina, L. Vila, K. Beyere, and H. A. Sampson. 2001. Identification of IgE and IgG binding epitope on β- and κ-casein in cow's milk-allergic patients. Clin. Exp. Allergy 31:1256-1262.
7. Chuchacovich, M., H. Gatica, H. S. V. Pizzo, and M. Gonzalez-Gronow. 2001. Characterization of human serum dipeptidylpeptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases. Clin. Exp. Rheumatol. 19:673-680.
8. Chuchacovich, M., H. Gatica, P. Vial, J. Yovauovich, S. V. Pizzo, and M. Gonzalez-Gronow. 2002. Streptokinase promotes development of dipeptidyl peptidase IV (CD26) autoantibodies after fibrinolytic therapy in myocardial infarction patients. Clin. Diagn. Lab. Immunol. 9:1253-1259.
9. Ciervo, A., P. Visca, A. Petrucca, L. M. Biasucci, A. Maseri, and A. Cassone. 2002. Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease. Clin. Diagn. Lab. Immunol. 9:66-74.
10. Comi, A. M., A. W. Zimmerman, V. H. Frye, P. A. Law, and J. N. Peeden. 1999. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child. Neurol. 14:388-394.
11. Delmas, B., J. Gelfi, R. L'Haridon, K. Vogell, H. Sjostrom, O. Noren, and H. Laude. 1992. Aminopeptidase is a major receptor for the enteropathogenic coronavirus TGEV. Nature 357:417-420.
12. Drexler, H. G. 1987. Classification of acute myeloid leukemias-a comparison of FAB immunophenotyping. Leukemia 1:697-705.
13. Dropcho, E. J., Y. Chen, J. B. Posner, and L. J. Old. 1987. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. J. Immunol. 84:4552-4556.
14. Edelson, S. B., and D. S. Cantor. 2000. The neurotoxic etiology of the autistic spectrum disorder: a replicative study. Toxicol. Ind. Health 16:239-247.
15. Fielder, A. H., M. J. Walport, J. R. Batchelor, et al. 1983. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br. Med. J. 286:425-428.
16. Frustaci, A., L. Cuoco, C. Chimenti, M. Pieroni, G. Fioravanti, N. Gentilon, A. Maseri, and G. Gasbarrini. 2002. Celiac disease associated with autoimmune myocarditis. Circulation 105:2611-2618.
17. Goding, J. W. 1978. Use of staphylococcal protein A as an immunological reagent. J. Immunol. Methods 20:241-253.
18. Gonzalez-Gronow, M., M. R. Weber, G. Gawdi, and S. V. Pizzo. 1998. Dipeptidylpeptidase IV (CD26) is a receptor for streptokinase on rheumatoid synovial fibroblasts. Fibrinolysis Proteolysis 12:129-135.
19. Gonzalez-Gronow, M., M. Cuchacovich, D. M. Grigg, and S. V. Pizzo. 1996. Analysis of autoantibodies to plasminogen in the serum of patients with rheumatoid arthritis. J. Mol. Med. 74:463-469.
20. Gupta, S., T. Lee, and S. Aggarval. 1998. Alterations in Th1 and Th2 subsets of CD4+ and CD8+ T-cells in autism. J. Neuroimmunol. 14:499-504.
21. Hadjivassiliou, M., S. Boscolos, G. A. B. Davies-Jones, R. A. Grünwald, T. Not, D. S. Sanders, J. E. Simpson, E. Tongiorgi, C. A. Williamson, and N. M. Woodroofe. 2002. The humoral response in the pathogenesis of gluten ataxia. Neurology 58:1221-1226.
22. Harat, S. D., N. Yacov, B. Gilburd, Y. Shoenfeld, and J. George. 2002. Oral tolerance with heat shock protein-65 attenuates mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J. Am. Coll. Cardiol. 40:1333-1338.
23. Harlow, E., and D. Lane (ed.). 1988. Antibodies: a laboratory manual, p. 98-108. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
24. Hartun, H. P., G. Stoll, and K. V. Toyka. 1993. Immune reactions in the peripheral nervous system, p. 418-444. In P. J. Dyck, P. K. Thomas, J. W. Griffin, et al. (ed.) Peripheral neuropathy. W. B. Saunders, Philadelphia, Pa.
25. Hildebrandt, M., W. Reutter, P. Arck, M. Rose, and B. Klapp. 2000. A guardian angel: the involvement of dipeptidylpeptidase IV in psychoneuroendocrine function, nutrition and immune defense. Clin. Sci. 99:93-104.
26. Jyonouchi, H., S. N. Sun, and H. Le. 2001. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 120:170-179.
27. Kameoka, J., T. Tanaka, Y. Nojima, S. F. Schlossman, and C. Morimoto. 1993. Direct association of adenosine deaminase with a T-cell activation antigen, CD26. Science 261:466-469.
28. Kol, A., T. Bourcier, A. H. Lichtman, and P. Libby. 1991. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells and macrophages. J. Clin. Investig. 103:571-577.
29. Letarte, M., S. Vera, R. Tran, J. B. L. Addis, R. J. Onizuka, E. J. Quackenbush, C. V. Jongeneel, and R. R. McInnes. 1988. Common acute lymphocyte leukemia antigen is identical to endopeptidase. J. Exp. Med. 168:1247-1253.
30. Look, A. T., R. A. Ashmun, L. H. Shapiro, and S. H. Peiper. 1989. Human myeloid plasma membrane glucoprotein CD13 (gP150) is identical to aminopeptidase N. J. Clin. Investig. 83:1299-1307.
31. + T-cell development and differentiation. J. Immunol. 150:5880-5885.
32. Matsas, R., S. L. Stephenson, J. Hryszko, A. J. Turner, and A. J. Kenny. 1985. The metabolism of neuropeptides; phase separation of synaptic membrane preparations with Triton X-114 reveals presence of aminopeptidase N. Biochem. J. 231:445-449.
33. Misumi, Y., Y. Hayashi, F. Arakawa, and Y. Ikehara. 1992. Molecular cloning and sequence analysis of human dipeptidyl peptidase IV, a serine proteinase on the cell surface. Biochim. Biophys. Acta 1131:333-336.
34. Money, J., N. A. Bobrow, and F. C. Clarke. 1971. Autism and autoimmune disease: a family study. J. Autism Child. Schizophr. 1:146-160.
35. Murray, D. L., D. H. Ohlendorf, and P. M. Schlievert. 1995. Staphylococcal and streptococcal superantigens: their role in human diseases. ASM News 61:229-235.
36. Muscat, C., A. Bertotto, E. Agea, O. Bistoni, R. Ercolani, R. Tognelli, F. Spinozzi, M. Cesarotti, and R. Gerli. 1994. Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid cells in rheumatoid arthritis patients. Clin. Exp. Immunol. 98:252-256.
37. Nakao, H., K. Eguchi, A. Kawakami, K. Migita, Y. Otsubo, C. Ueki, H. Shimomura, M. Tezuka, K. Maeda Matsunaga, and S. Nagataki. 1989. Increment of Tal positive cells in peripheral blood from patients with rheumatoid arthritis. J. Rheumatol. 16:904-914.
38. Prahalad, S., E. S. Shear, S. D. Thompson, E. H. Giannini, and D. N. Glass. 2002. Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. Arthritis Rheum. 46:1851-1856.
39. Riemann, D., A. Kehlen, and J. Langner. 1999. CD13-not just a marker in leukemia typing. Immunol. Today 20:83-88.
40. Sentandrau, M. A., and F. Toldra. 2000. Purification and biochemical properties of dipeptidylpeptidase I from porcine skeletal muscle. J. Agric. Food Chem. 48:5014-5022.
41. Shan, L., O. Molberg, I. Parrot, F. Hausch, F. Filiz, G. M. Gray, L. M. Sollid, and C. Khosla. 2002. Structural basis for gluten intolerance in celiac sprue. Science 297:2275-2279.
42. Singh, V. K., R. P. Warren, R. Averett, and M. Ghaziuddin. 1997. Circulating autoantibodies to neuronal and glial filament protein in autism. Pediatr. Neurol. 17:88-90.
43. Sollid, L. M. 2002. Coeliac disease: dissecting a complex inflammatory disorder. Nat. Rev. Immunol. 2:647-655.
44. Squire, I. B., W. Lawley, S. Fletcher, E. Holme, W. S. Hillis, C. Hewitt, and K. L. Woods. 1999. Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction. Eur. Heart J. 20:1245-1252.
45. Stancikova, M., Z. Lojda, J. Lukac, and M. Ruzickova. 1992. Dipeptidylpeptidase IV in patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 10:381-385.
46. Stastny, P. 1978. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N. Engl. J. Med. 298:869-871.
47. Stöllberger, C., and J. Finsterer. 2002. Role of infections and immune factors in coronary and cerebrovascular arteriosclerosis. Clin. Diagn. Lab. Immunol. 9:207-215.
48. Sweeten, T. L., S. L. Bowyer, D. J. Posey, et al. 2003. Increased prevalence of familial autoimmunity in probands with pervasive development disorders. Pediatrics 112:420-424.
49. Torres, A. R., A. Maciulis, E. G. Stubbs, A. Cutler, and D. Odell. 2002. The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Hum. Immunol. 63:311-316.
50. van Gent, T., C. J. Heijnen, and P. D. A. Treffers. 1997. Autism and the immune system. J. Child. Psychol. Psychiatry 38:337-349.
51. Vojdani, A., A. W. Campbell, E. Anyanwu, A. Kashanian, K. Bock, and E. Vojdani. 2002. Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and streptococcus group A. J. Neuroimmunol. 129:168-177.
52. Wakefield, A. J., S. H. Murch, A. Anthony, J. Linnell, D. M. Casson, M. Malik, M. Berelowitz, M. A. Thomson, P. Harvey, A. Valetine, S. E. Davies, and J. A. Walker-Smith. 1998. Ileal-lymphoid-nodular hyperplasia, nonspecific colitis, and pervasive developmental disorder in children. Lancet 351:637-641.
53. Warren, R. P., A. Foster, N. C. Margaretten, N. C. Pace, and A. Foster. 1986. Immune abnormalities in patients with autism. J. Autism Dev. Disord. 16:189-197.
54. Warren, R. P., A. Foster, and N. C. Margarette. 1987. Reduced natural killer activity in autism. J. Am. Acad. Child Adolesc. Psychiatry 26:333-335.
55. Warren, R. P., V. K. Singh, P. Cole, et al. 1991. Increased frequency of the null allele at the complement C4B locus in autism. Clin. Exp. Immunol. 83:438-440.
56. Warren, R. P., V. K. Singh, P. Cole, et al. 1992. Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics 36:203-207.
57. Warren, R. P., V. K. Singh, R. E. Avernett, et al. 1996. Immunogenetic studies in autism and related disorders. Mod. Chem. Neuropathol. 28:77-81.
58. Weizman, A., R. Weizman, G. A. Szekely, H. Wijsenbeek, and E. Livni. 1982. Abnormal immune response to brain tissue antigen in the syndrome of autism. Am. J. Psychiatry 139:1462-1465.
59. Wolters, P. J., M. Laig-Webster, and G. H. Caughey. 2000. Dipeptidyl peptidase I cleaves matrix-associated proteins and is expressed mainly by mast cells in normal dog airways. Am. J. Respir. Cell. Mol. Biol. 22:183-190.
60. Yamazaki, K., Y. Ohsawa, K. Tabeta, H. Ito, K. Ueki, T. Oda, H. Yoshie, and G. J. Seymour. 2002. Accumulation of heat shock protein 60-reactive T cells in the gingival tissues of periodontitis patients. Infect. Immun. 70:2492-2501.
61. Yeager, C. L., R. A. Ashmun, R. K. Williams, C. B. Cardellichio, L. H. Shapiro, A. T. Look, and K. V. Holmes. 1992. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357:420-422.
62. Yonk, L. J., R. P. Warren, R. A. Burger, P. Cole, J. D. Odell, W. R. Warren, E. White, and V. K. Singh. 1990. CD4+ helper T-cell depletion in autism. Immunol. Lett. 25:344-346.
63. York, I. A., S. C. Chang, T. Saric, et al. 2002. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3:1177-1184.
64. Young, R. A., and T. J. Elliot. 1989. Stress proteins, infection, and immune surveillance. Cell 59:5-8.